Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the Covid-19 Pandemic: A Review of Current Literature Publisher Pubmed



Rahimi L1 ; Malek M2 ; Ismailbeigi F1 ; Khamseh ME3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medicine, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, 44106, OH, United States
  2. 2. Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran
  3. 3. Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran

Source: Advances in Therapy Published:2020


Abstract

The COVID-19 outbreak was declared a pandemic on March 2020. Many patients with SARS-CoV-2 infection have underlying chronic medical conditions such as diabetes, cardiovascular disease (CVD), and hypertension. Patient-related outcomes are worse if there are associated comorbidities. We do not have enough evidence regarding the most appropriate management of patients with diabetes during COVID-19 infection. Insulin resistance and CVD together increase the inflammatory state of the body, which can contribute to and perhaps mediate the increase of COVID-19 severity. Hence, in addition to management of dysglycemia, other CVD risk factors should be targeted. We explore the possible pathophysiologic links between diabetes and COVID-19 and discuss various options to treat dysglycemia, hypertension, and dyslipidemia in the era of COVID-19. © 2020, The Author(s).
Other Related Docs
12. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
13. Covid-19 in Patients With Hypertension, Advances in Experimental Medicine and Biology (2021)
24. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
34. Management of Environmental Health to Prevent an Outbreak of Covid-19: A Review, Environmental and Health Management of Novel Coronavirus Disease (COVID-19) (2021)
36. Factors Associated With the Poor Outcomes in Diabetic Patients With Covid-19, Journal of Diabetes and Metabolic Disorders (2020)
43. Bibliometric Analysis of Global Scientific Research on Coronavirus (Covid-19), Medical Journal of the Islamic Republic of Iran (2020)
46. Cardiovascular Manifestations in Covid-19 Patients: A Systematic Review and Meta-Analysis, Journal of Cardiovascular and Thoracic Research (2021)